Ocugen Inc Revenue per Employee (OCGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ocugen Inc   (NASDAQ: OCGN)
 

Ocugen Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.38% in the second quarter 2026, year on year to cumulative value of $5 million, Ocugen Inc 's revenue per employee grew on a trailing twelve months basis to $ 39,483, this is below the company average.
Within the Healthcare sector Employees of 513 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3546, from total ranking in previous quarter at 4209. Ocugen Inc has 116 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCGN Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 8.38 % 3.51 % - 54.23 % 20.33 %
Sales per Employee (TTM) $ 39,483 38,491 38,043 46,293 40,983
OCGN's Total Ranking # 3546 # 4209 # 3655 # 3699 # 3735
Seq. Revenue Change -2.94 % - - 27.6 % -7.29 %

OCGN Company Profile >> Back to OCGN Efficiency Comparisons >> Compare OCGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 63
Healthcare Sector # 514
Overall Market # 3546

Revenue per Employee Statistics
High Average Low
$ 62,612 $ 44,487 $ 34,957
(Jun 30 2024)   (Dec 31 2024)



Financial Statements
Ocugen Inc 's Revenue MRQ $ 1 Millions Visit OCGN's Income Statement
Ocugen Inc 's Revenues TTM $ 5 Millions Visit OCGN's aggregate revenue growth
What are OCGN's Sales? Visit OCGN's Sales by Segment




Other Ratios
Ocugen Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OCGN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OCGN's Competitors
Revenue per Employee for OCGN's Suppliers
Revenue per Employee for OCGN's Customers

You may also want to know
OCGN's Sales Growth Rates OCGN's Pe Price to earnings ratio OCGN's Receivables Turnover Ratio OCGN's Stock Quote
OCGN's Net Income Growth Rates OCGN's Ps Price to Sales ratio OCGN's Sales per Employee OCGN's Asset Turnover Ratio
OCGN's Net Margin OCGN's Pb Price to Book ratio OCGN's Financial Strength Ratios OCGN's Dividend Payout Ratio
Date modified: 2026-09-08T21:20:38+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Sharps Technology Inc   67,593.76 $ 1.960  Million 29 
Ispecimen inc   66,614.57 $ 0.466  Million 7 
Lucid Diagnostics Inc   66,402.44 $ 5.445  Million 82 
Cannapharmarx Inc   65,342.92 $ 1.699  Million 26 
Agape Atp Corporation  64,026.78 $ 1.152  Million 18 
Vistagen Therapeutics Inc   61,000.00 $ 2.501  Million 41 
Blue Water Vaccines Inc  58,711.64 $ 0.646  Million 11 
Dar Bioscience Inc   56,031.96 $ 1.345  Million 24 
Petvivo Holdings Inc   53,712.00 $ 1.182  Million 22 
Vsee Health Inc   51,479.38 $ 10.759  Million 209 
Tscan Therapeutics Inc   50,077.46 $ 7.111  Million 142 
Cg Oncology Inc   43,859.15 $ 6.228  Million 142 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Upstream Bio Inc   42,106.67 $ 3.158  Million 75 
Sintx Technologies Inc   41,562.50 $ 1.330  Million 32 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Ocugen Inc   39,482.76 $ 4.580  Million 116 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Entrada Therapeutics Inc   30,828.95 $ 4.686  Million 152 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Seres Therapeutics Inc   28,530.30 $ 1.883  Million 66 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Prime Medicine Inc   27,897.26 $ 4.073  Million 146 
Nexalin Technology Inc   27,144.38 $ 0.217  Million 8 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.